Published in World J Gastroenterol on June 01, 2000
The prognostic significance of clinical and pathological features in hepatocellular carcinoma. World J Gastroenterol (2002) 2.03
Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients. Br J Cancer (2005) 1.51
High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma. World J Gastroenterol (2002) 1.25
Comparison between chemoembolization combined with radiotherapy and chemoembolization alone for large hepatocellular carcinoma. World J Gastroenterol (2003) 1.20
Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score. World J Gastroenterol (2002) 1.19
Brain metastasis of hepatocellular carcinoma: A case report and review of the literature. World J Gastroenterol (2004) 1.01
Expression of p53 and C-myc genes and its clinical relevance in the hepatocellular carcinomatous and pericarcinomatous tissues. World J Gastroenterol (2002) 0.93
DNA-PKcs subunits in radiosensitization by hyperthermia on hepatocellular carcinoma hepG2 cell line. World J Gastroenterol (2002) 0.89
Influence of hepatic arterial blockage on blood perfusion and VEGF, MMP-1 expression of implanted liver cancer in rats. World J Gastroenterol (2002) 0.89
Percutaneous transsplenic embolization of esophageal and gastrio-fundal varices in 18 patients. World J Gastroenterol (2001) 0.88
Expression of liver cancer associated gene HCCA3. World J Gastroenterol (2001) 0.83
Gene expression profiles of hepatoma cell line HLE. World J Gastroenterol (2003) 0.83
A novel diagnostic marker, p28GANK distinguishes hepatocellular carcinoma from potential mimics. J Cancer Res Clin Oncol (2004) 0.81
Role of preoperative selective portal vein embolization in two-step curative hepatectomy for hepatocellular carcinoma. World J Gastroenterol (2003) 0.77
Preparation and characterization of polyclonal antibodies against ARL-1 protein. World J Gastroenterol (2003) 0.77
Concurrent hyperglycemia does not influence the long-term prognosis of unresectable hepatocellular carcinomas. World J Gastroenterol (2003) 0.76
Acute Cholecystitis Complicated with Portal Vein Thrombosis: A Case Report and Literature Review. Am J Case Rep (2015) 0.75
Economic evaluation of pegylated interferon plus ribavirin for treatment of chronic hepatitis C in Thailand: genotype 1 and 6. BMC Gastroenterol (2016) 0.75
Construction and expression of recombined human AFP eukaryotic expression vector. World J Gastroenterol (2003) 0.75
Transection of the oesophagus for bleeding oesophageal varices. Br J Surg (1973) 26.26
Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet (1981) 13.54
Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer (1985) 7.67
A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire. N Engl J Med (1995) 6.75
Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology (1999) 5.64
Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology (1998) 3.62
NIH conference. Hepatocellular carcinoma. Ann Intern Med (1988) 2.94
Treatment of hepatocellular carcinoma with tamoxifen: a double-blind placebo-controlled trial in 120 patients. Gastroenterology (1995) 2.47
Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer (1996) 2.26
Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients. Cancer (1989) 1.85
Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma. Clin Cancer Res (1999) 1.77
Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients. Gastroenterology (1986) 1.76
Hepatocellular carcinoma. Diagnostic and prognostic features in North American patients. Cancer (1984) 1.54
The natural history of hepatocellular carcinoma. A study of 100 untreated cases. Cancer (1984) 1.53
Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients. Hepatology (1990) 1.52
Prognostic factors in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusion. Cancer (1991) 1.36
Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Hepatology (1992) 1.24
Hepatocellular carcinoma in rural southern African blacks. Medicine (Baltimore) (1982) 1.14
Natural course of small hepatocellular carcinoma with underlying cirrhosis. A study of 30 patients. Hepatogastroenterology (1998) 0.92
Primary hepatocellular carcinoma in women of mainland China. A clinicopathologic analysis of 104 patients. Cancer (1993) 0.90
Factors affecting the prognosis of primary liver carcinoma. J Clin Oncol (1988) 0.89
The natural history of hepatocellular carcinoma in Western countries. Hepatogastroenterology (1998) 0.86
Hepatitis B: transmission and natural history. Gut (1993) 0.86
Primary liver cancer. Quadrennial review lecture. Dig Dis Sci (1986) 0.86
Serological markers of hepatitis B virus and alpha-fetoprotein levels preceding primary hepatocellular carcinoma in Alaskan Eskimos. Lancet (1982) 0.84
Progress on the control of hepatitis B infection through immunisation. Gut (1993) 0.84
The clinical manifestations and natural history of hepatocellular carcinoma. Gastroenterol Clin North Am (1987) 0.82
Hepatocellular carcinoma: molecular biology, etiology and animal models. Gastroenterol Clin North Am (1987) 0.82
Screening studies and markers. Gastroenterol Clin North Am (1987) 0.78
Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B. N Engl J Med (2005) 7.18
Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B. N Engl J Med (2004) 5.40
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int (2008) 5.25
A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int (2011) 3.69
Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B. Hepatology (2009) 3.02
Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B. Clin Gastroenterol Hepatol (2007) 2.16
HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B. Hepatology (2008) 2.11
Liver biopsy:complications and risk factors. World J Gastroenterol (1999) 1.91
Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report. J Hepatol (2011) 1.86
Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa. Gastroenterology (2009) 1.76
Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha-2a. Liver Int (2008) 1.56
Sustained response of hepatitis B e antigen-negative patients 3 years after treatment with peginterferon alpha-2a. Gastroenterology (2009) 1.48
A global view of hepatitis C: physician knowledge, opinions, and perceived barriers to care. Hepatology (2013) 1.46
HIV DNA reservoir increases risk for cognitive disorders in cART-naïve patients. PLoS One (2013) 1.27
Response-guided peginterferon therapy in hepatitis B e antigen-positive chronic hepatitis B using serum hepatitis B surface antigen levels. Hepatology (2013) 1.26
Pathogenesis of HIV in the central nervous system. Curr HIV/AIDS Rep (2011) 1.26
Practical difficulties in the management of hepatitis B in the Asia-Pacific region. J Gastroenterol Hepatol (2004) 1.09
HIV DNA and dementia in treatment-naïve HIV-1-infected individuals in Bangkok, Thailand. Int J Med Sci (2006) 1.04
Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions. Hepatol Int (2010) 1.03
An outbreak of botulism in Thailand: clinical manifestations and management of severe respiratory failure. Clin Infect Dis (2006) 1.03
Spinal cord compression and bilateral sensory neural hearing loss: an unusual manifestation of neurocysticercosis. J Med Assoc Thai (2004) 0.97
Development of normative neuropsychological performance in Thailand for the assessment of HIV-associated neurocognitive disorders. J Clin Exp Neuropsychol (2012) 0.92
Global NeuroAIDS roundtable. J Neurovirol (2013) 0.92
The value of Carlsson-dent questionnaire in diagnosis of gastroesophageal reflux disease in area with low prevalence of gastroesophageal reflux disease. J Neurogastroenterol Motil (2011) 0.91
Expression of monocyte markers in HIV-1 infected individuals with or without HIV associated dementia and normal controls in Bangkok Thailand. J Neuroimmunol (2008) 0.89
Dural sinus thrombosis in melioidosis: the first case report. J Med Assoc Thai (2006) 0.89
Mastectomy without drain at pectoral area: a randomized controlled trial. J Med Assoc Thai (2003) 0.88
Correlation of arterial, central venous and capillary lactate levels in septic shock patients. J Med Assoc Thai (2011) 0.86
Psychometric properties of the Thai version of the 22-item and 45-item Karasek job content questionnaire. Int J Occup Med Environ Health (2008) 0.86
Cost-effectiveness analysis of roadmap models in chronic hepatitis B using tenofovir as the rescue therapy. Antivir Ther (2010) 0.85
Prevalence of hazardous-harmful drinking in a southern Thai community. Drug Alcohol Rev (2003) 0.85
Contextual and individual demographic determinants of alcohol consumption and smoking: a comparative study in southwestern China and southern Thailand. Southeast Asian J Trop Med Public Health (2009) 0.84
Contemporary outcomes in women undergoing percutaneous coronary intervention for acute coronary syndromes. Int J Cardiol (2010) 0.84
Clinical features, etiology, and survival of hepatocellular carcinoma among different countries. J Gastroenterol Hepatol (2002) 0.82
Further analysis is required to identify an early stopping rule for peginterferon therapy that is valid for all hepatitis B e antigen-positive patients. Hepatology (2011) 0.82
Comparison between aspirin combined with dipyridamole versus aspirin alone within 48 hours after ischemic stroke event for prevention of recurrent stroke and improvement of neurological function: a preliminary study. J Med Assoc Thai (2005) 0.82
Histologic subtypes of hepatocellular carcinoma in the southern Thai population. Asian Pac J Cancer Prev (2004) 0.81
Association between brain volumes and HAND in cART-naïve HIV+ individuals from Thailand. J Neurovirol (2015) 0.81
Accuracy in diagnosis of acute appendicitis by comparing serum C-reactive protein measurements, Alvarado score and clinical impression of surgeons. J Med Assoc Thai (2004) 0.80
High-frequency oscillatory ventilation for patients during exudative phase of severe ARDS. J Med Assoc Thai (2015) 0.80
HIV DNA in CD14+ reservoirs is associated with regional brain atrophy in patients naive to combination antiretroviral therapy. AIDS (2014) 0.80
Electrophysiological diagnosis and patterns of response to treatment of botulism with neuromuscular respiratory failure. Muscle Nerve (2009) 0.79
Risk factors of hepatitis C virus infection in blood donors in Thailand: a multicenter case-control study. J Med Assoc Thai (2006) 0.79
Frequency and characteristics of HIV-associated sensory neuropathy among HIV patients in Bangkok, Thailand. J Acquir Immune Defic Syndr (2008) 0.79
Trail Making Test A improves performance characteristics of the International HIV Dementia Scale to identify symptomatic HAND. J Neurovirol (2013) 0.79
Sex differences in soluble markers vary before and after the initiation of antiretroviral therapy in chronically HIV-infected individuals. AIDS (2016) 0.79
Diagnostic markers of chronic hepatitis B infection and disease. Antivir Ther (2010) 0.78
Comparison of prevalence of post-dural puncture headache between six hour- supine recumbence and early ambulation after lumbar puncture in thai patients: A randomized controlled study. J Med Assoc Thai (2006) 0.78
Reimbursement policies in the Asia-Pacific for chronic hepatitis B. Hepatol Int (2014) 0.78
Peripheral T-lymphocyte subpopulations in different clinical stages of chronic HBV infection correlate with HBV load. World J Gastroenterol (2009) 0.78
Treatment of chronic hepatitis B in Asia-Pacific countries: is the Asia-Pacific consensus statement being followed? Antivir Ther (2010) 0.78
Avoiding and managing lamivudine resistance in chronic hepatitis B: current approaches and potential strategies including pegylated interferon. Liver Int (2010) 0.77
Nephrogenic systemic fibrosis risk after liver magnetic resonance imaging with gadoxetate disodium in patients with moderate to severe renal impairment: results of a prospective, open-label, multicenter study. Invest Radiol (2015) 0.77
Evaluation of correlation between vascular pedicle width and intravascular volume status in Thai critically ill patients. J Med Assoc Thai (2011) 0.77
Influence of meal intake on liver stiffness in patients with chronic hepatitis B and C. J Med Assoc Thai (2014) 0.77
Neuronal-Glia Markers by Magnetic Resonance Spectroscopy in HIV Before and After Combination Antiretroviral Therapy. J Acquir Immune Defic Syndr (2016) 0.77
Practice effect and normative data of an HIV-specific neuropsychological testing battery among healthy Thais. J Med Assoc Thai (2014) 0.77
Does a SCN1A gene mutation confer earlier age of onset of febrile seizures in GEFS+? Epilepsia (2009) 0.77
Clinical manifestation and survival of patients with small-cell lung cancer. J Med Assoc Thai (2007) 0.77
Prevalence of depression among epileptic patients at Phramongkutklao Hospital. J Med Assoc Thai (2007) 0.77
Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infection. J Gastroenterol Hepatol (2015) 0.76
Prophylactic botulinum type A toxin complex (Dysport®) for migraine without aura. Headache (2010) 0.76
Therapeutic goal achievements during severe sepsis and septic shock resuscitation and their association with patients' outcomes. J Med Assoc Thai (2014) 0.76
Impact of septic shock hemodynamic resuscitation guidelines on rapid early volume replacement and reduced mortality. J Med Assoc Thai (2010) 0.76
Brief Report: CD14+ Enriched Peripheral Cells Secrete Cytokines Unique to HIV-Associated Neurocognitive Disorders. J Acquir Immune Defic Syndr (2017) 0.75
Prevalence of poststroke depression in Thai stroke survivors studied in Phramongkutklao Hospital. J Med Assoc Thai (2010) 0.75
Comparison between Computer Tomography and Magnetic Resonance Imaging in the Diagnosis of Small Hepatocellular Carcinoma Asian Pac J Cancer Prev (2016) 0.75
Transthoracic imaging-guided biopsy of lung lesions: evaluation of benign non-specific pathologic diagnoses. J Med Assoc Thai (2015) 0.75
Transthoracic echocardiogram for the diagnosis of right ventricular dysfunction in critically ill patients. J Med Assoc Thai (2014) 0.75
Behavioral and psychological symptoms of dementia. J Med Assoc Thai (2014) 0.75
Factors influencing MMSE-T score among Thai subjects. J Med Assoc Thai (2005) 0.75
Gender and ethnic differences in cardiovascular risks in Songkhla province, Thailand: the interASIA-south. J Med Assoc Thai (2008) 0.75
Multifocal epilepsy: the role of palliative resection - intractable frontal and occipital lobe epilepsy secondary to radiotherapy for acute lymphoblastic leukaemia. Epileptic Disord (2008) 0.75
The Changes in Mean Platelet Volume after Using of Antiplatelet Drugs in Acute Ischemic Stroke: A Randomized Controlled Trial. J Med Assoc Thai (2015) 0.75
Excessive daytime sleepiness and obstructive sleep apnea in Thai epileptic patients. J Med Assoc Thai (2014) 0.75
Non-motor symptoms in Thai patients with Parkinson's disease studied at Phramongkutklao Hospital. J Med Assoc Thai (2014) 0.75
Invasive streptococcal group A infection and toxic shock syndrome in Songklanagarind hospital. J Med Assoc Thai (2002) 0.75
Accuracy of the mammographic report category according to BIRADS. J Med Assoc Thai (2005) 0.75
Dynamics of central venous oxygen saturation and serum lactate during septic shock resuscitation. J Med Assoc Thai (2013) 0.75
Hypothalamic neurocysticercosis presenting with polyuria: a first report of an unusual manifestation. Nephrol Dial Transplant (2005) 0.75